Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio Post ContentvndaRead More You might also be interested in reading Airwallex Signs Arsenal FC After $300M Funding Round. February 14, 2025 In Mainstream ← Previous post Next post →